急性冠状动脉综合征患者预后评价指标的临床意义

Clinical Significance of Prognosis Evaluation Indicators in Acute Coronary Syndromes Patients

急性冠状动脉综合征(ACS)是近年来引起心血管疾病死亡的主要原因,具有发病急、速度快、病死率高、预后差的特点。生化指标对有ACS表现及征象患者的诊断、预后、指导治疗有重要作用。然而,如何选择最理想的心脏标志物(或标志的组合)仍然存在争议。如何利用现有的临床指标快速、有效地评价ACS是近年来国内外研究的重点,本研究旨在探讨多种生物标志物水平的关系。现对ACS相关临床生化指标进行综述,为ACS日后的临床诊治及预后评估提供依据。

Acute coronary syndrome（ ACS） is one of the leading causes of death in China.Biomarkers have an essential role in diagnosis,prognosis,guiding the treatment of patients presenting with signs and symptoms of ACS.However,the selection of the most optimal cardiac marker,or combination of markers,remains controversial.In recent years,ACS has become the leading cause of death from cardiovascular disease,with acute onset,fast speed,high mortality rate and poor prognostic features.How to use the existing clinical indicators of rapid,effective evaluation of ACS is the focus of research at home and abroad.This study aims to investigate the relationship in level of several biomarkers.ACS clinical biochemical indexes were reviewed to provide references for the clinical diagnosis and treatment and prognosis evaluation of ACS in the future.